Digital Implementing generative AI: A guide for commercial life scie... In a market saturated with articles highlighting the potential of generative AI, it’s crucial to also understand its limitations.
Digital Why security-first design is the fix to stalling AI pilot to... For AI to be transformative in the pharmaceutical industry, it must be designed with a security-first approach.
News J&J jumps on the MFN pricing train Johnson & Johnson is the latest pharma group to agree a Most-Favoured Nation (MFN) drug pricing deal with the Trump administration to avert tariffs.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.